Award notice Supplies

Medicamentos exclusivos con principios activos erenumab, fremanezumab y galcanezumab de varios laboratorios farmacéuticos

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer: Servicio Murciano de Salud - Junta de Compras
Espinardo
Place of performance: Espinardo
Estimated value: €9,471,998 excl. VAT
Amount awarded: €3,508,148 excl. VAT
Bids received: 1
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 17 September 2026
Notice language: Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Unlimited analyses during the 14-day Pro trial, no card needed.

Medicamentos exclusivos con principios activos erenumab, fremanezumab y galcanezumab de varios laboratorios farmacéuticos

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33661200

Contract	Winner	Amount
Suministro de adquisición del Vabysmo 120 mg/ml solución para inyección en jeringa precargada y Vabysmo 120 mg/ml solución inyectable para inyección, (Faricimab), para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal. Hospital Universitario Ramón y Cajal · 7 July 2026	ROCHE FARMA SAU	€1,511,305
Suministro sucesivo del medicamento ONASEMNOGEN ABEPARVOVEC para el Área Sanitaria de Santiago de Compostela e Barbanza. Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza · 6 July 2026	NOVARTIS FARMACEUTICA, S.A.	€32,160,000

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 642159-2026.